Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sun, C.-A.
Right arrow Articles by Santella, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, C.-A.
Right arrow Articles by Santella, R. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 8, 1289-1294, August 2001
© 2001 Oxford University Press


CARCINOGENESIS

Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case–control study in Taiwan

Chien-An Sun1,6, Li-Yu Wang2, Chien-Jen Chen3, Sheng-Nan Lu4, San-Lin You3, Lian-Wen Wang5, Qiao Wang5, Der-Ming Wu1 and Regina M. Santella5

1 School of Public Health, National Defense Medical Center, Taipei, Taiwan,
2 Institute of Aboriginal Health, Tzu Chi University, Hualien County, Taiwan,
3 Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan,
4 Liver Unit, Kaohsiung Medical Center, Chang Gung Memorial Hospital, Kaohsiung County, Taiwan, Republic of China and
5 Division of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA

This study was conducted to investigate the modifying effect of glutathione S-transferase (GST) M1 and T1 polymorphisms on aflatoxin-induced hepatocarcinogenesis among chronic hepatitis B virus surface antigen (HBsAg) carriers. A total of 79 HBsAg-positive cases of hepatocellular carcinoma (HCC) diagnosed between 1991 and 1997 were identified and individually matched to one or two HBsAg-positive controls on age, gender, residence and date of recruitment from the same cancer screening cohort in Taiwan. Blood samples were tested for hepatitis B and C viral markers by enzyme immunoassay and for aflatoxin B1 (AFB1)–albumin adducts by competitive enzyme-linked immunosorbent assay. GSTM1 and GSTT1 genotypes were determined by PCR. There was a statistically significant relationship between detectable levels of AFB1–albumin adducts in serum and risk of HCC among chronic HBsAg carriers, with an adjusted odds ratio (OR) of 2.0 [95% confidence interval (CI) 1.1–3.7]. In addition, the effect of aflatoxin exposure on HCC risk was more pronounced among chronic HBsAg carriers with the GSTT1 null genotype (OR 3.7, 95% CI 1.5–9.3) than those who were non-null (OR 0.9, 95% CI 0.3–2.4). The interaction between serum AFB1–albumin adduct level and GSTT1 genotype was statistically significant (P = 0.03). For GSTM1 the effect of aflatoxin exposure on HCC risk in those with the null genotype was also greater (adjusted OR 2.8, 95% CI 1.0–7.8) than in those with the gene present (adjusted OR 1.8, 95% CI 0.8–4.5), but the difference was not significant (P = 0.91). Notably, when the interaction between aflatoxin exposure and GSTT1 genotype was considered, aflatoxin exposure by itself was not a significant determinant of HCC risk among chronic HBsAg carriers. These results demonstrate the importance of gene–environment interactions in the multifactorial development of HCC.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
J. D Thrasher and S. Crawley
The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes
Toxicology and Industrial Health, October 1, 2009; 25(9-10): 583 - 615.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H.-C. Wu, Q. Wang, H.-I Yang, H. Ahsan, W.-Y. Tsai, L.-Y. Wang, S.-Y. Chen, C.-J. Chen, and R. M. Santella
Aflatoxin B1 Exposure, Hepatitis B Virus Infection, and Hepatocellular Carcinoma in Taiwan
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 846 - 853.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. L. White, D. Li, Z. Nurgalieva, and H. B. El-Serag
Genetic Variants of Glutathione S-Transferase as Possible Risk Factors for Hepatocellular Carcinoma: A HuGE Systematic Review and Meta-Analysis
Am. J. Epidemiol., February 15, 2008; 167(4): 377 - 389.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H.-C. Wu, Q. Wang, L.-W. Wang, H.-I Yang, H. Ahsan, W.-Y. Tsai, L.-Y. Wang, S.-Y. Chen, C.-J. Chen, and R. M. Santella
Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan
Carcinogenesis, May 1, 2007; 28(5): 995 - 999.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
C P Wen, S P Tsai, T Y Cheng, C-J Chen, D T Levy, H-J Yang, and M P Eriksen
Uncovering the relation between betel quid chewing and cigarette smoking in Taiwan
Tob. Control, June 1, 2005; 14(suppl_1): i16 - i22.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
C P Wen, S P Tsai, C-J Chen, T Y Cheng, M-C Tsai, and D T Levy
Smoking attributable mortality for Taiwan and its projection to 2020 under different smoking scenarios
Tob. Control, June 1, 2005; 14(suppl_1): i76 - i80.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. D. Kirk, P. C. Turner, Y. Gong, O. A. Lesi, M. Mendy, J. J. Goedert, A. J. Hall, H. Whittle, P. Hainaut, R. Montesano, et al.
Hepatocellular Carcinoma and Polymorphisms in Carcinogen-Metabolizing and DNA Repair Enzymes in a Population with Aflatoxin Exposure and Hepatitis B Virus Endemicity
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 373 - 379.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Rundle
Molecular Epidemiology of Physical Activity and Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 227 - 236.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M.-W. Yu, S.-Y. Yang, I-J. Pan, C.-L. Lin, C.-J. Liu, Y.-F. Liaw, S.-M. Lin, P.-J. Chen, S.-D. Lee, and C.-J. Chen
Polymorphisms in XRCC1 and Glutathione S-Transferase Genes and Hepatitis B-Related Hepatocellular Carcinoma
J Natl Cancer Inst, October 1, 2003; 95(19): 1485 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. A. McGlynn, K. Hunter, T. LeVoyer, J. Roush, P. Wise, R. A. Michielli, F.-M. Shen, A. A. Evans, W. T. London, and K. H. Buetow
Susceptibility to Aflatoxin B1-related Primary Hepatocellular Carcinoma in Mice and Humans
Cancer Res., August 1, 2003; 63(15): 4594 - 4601.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Rundle and S. Schwartz
Issues in the Epidemiological Analysis and Interpretation of Intermediate Biomarkers
Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 491 - 496.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Wang, T. K. Bammler, and D. L. Eaton
Complementary DNA Cloning, Protein Expression, and Characterization of Alpha-Class GSTs from Macaca fascicularis Liver
Toxicol. Sci., November 1, 2002; 70(1): 20 - 26.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.